SEC Form 4 · accession 0001177648-17-000018
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terry Vance
Director
Period of report
Feb 16, 2017
Accepted (ET)
Feb 21, 2017 · 7:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $29.02 | Feb 16, 2017 | A | 7,500 | A | — | Feb 16, 2027 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 16, 2017), with the final monthly installment vesting at the 2018 annual meeting of stockholders.